Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology Reports|October 2, 2015
Endometrioid adenocarcinoma arising from deep infiltrating endometriosis involving the bladder: A case report and review of the literatureYosuke Tarumi, Taisuke Mori, Izumi Kusuki, et al.
The Journal of Obstetrics and Gynaecology Research|October 30, 2024
A case of ovarian carcinosarcoma with germline BRCA2 pathogenic variantKaori Yoriki, Yuko Izumi, Yosuke Tarumi, et al.
The Journal of Obstetrics and Gynaecology Research|October 19, 2020
Successful detection of rectal injury during laparoscopic surgery using a rectal probe in a patient with deep endometriosisKaori Yoriki, Izumi Kusuki, Mari Kawamata, et al.
Cureus|January 12, 2026
Hysteroscopic Diagnosis of a Concurrent Placental Site Nodule and Cervical Adenocarcinoma: A Case ReportMai Yamazoe, Yosuke Tarumi, Sakura Yamamoto, et al.
Gynecologic Oncology Reports|September 19, 2022
Successful nedaplatin desensitization therapy in a patient with platinum-sensitive recurrent ovarian cancer: A case report and literature reviewTetsuya Kokabu, Kohei Aoyama, Yosuke Tarumi, et al.
The Journal of Obstetrics and Gynaecology Research|November 10, 2017
Long-term survival with bevacizumab in heavily pretreated and platinum-resistant mucinous ovarian cancer: A case reportYosuke Tarumi, Taisuke Mori, Hiroshi Matsushima, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 2, 2019
Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cellsTetsuya Kokabu, Taisuke Mori, Hiroshi Matsushima, et al.
Scientific Reports|June 18, 2022
Genistein induces long-term expression of progesterone receptor regardless of estrogen receptor status and improves the prognosis of endometrial cancer patientsKaori Yoriki, Taisuke Mori, Kohei Aoyama, et al.
Scientific Reports|May 2, 2019
Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancerKaori Yoriki, Taisuke Mori, Tetsuya Kokabu, et al.
Cancers|August 10, 2024
Effects of PARP Inhibitors on Subsequent Platinum-Based Chemotherapy in Patients with Recurrent Ovarian CancerTetsuya Kokabu, Yosuke Tarumi, Kota Aoki, et al.
Pageof 3